Product Information
FINASTERIDE 5 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0688 per EA under NDC 76282041290. Its NADAC has been published 669 times since Dec 11, 2013.
FDA first approved this application on Jun 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282041290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FINASTERIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090061FDA Approved
6/7/2010
TE Code
AB
On Market Since
5/22/2015
Pharmacological Classes
Price Statistics
The NADAC for FINASTERIDE 5 MG TABLET has been published 669 times since Dec 11, 2013, and over the history we have for it it has declined 60.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0688 per EA |
|---|---|
| All-time high | $0.2514 (Feb 12, 2014) |
| All-time low | $0.0565 (Nov 20, 2024) |
| 52-week high | $0.0707 |
| 52-week low | $0.0682 |
| Median price | $0.0824 |
| Average price | $0.0972 |
| Largest weekly change | +42.9% (Jan 22, 2014) |
| Weeks tracked | 669 |
| Tracking since | Dec 11, 2013 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Finasteride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
5-alpha Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FINASTERIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FINASTERIDE 5 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0688 per EA (NDC 76282041290), effective Sep 30, 2026.
How has the price of FINASTERIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FINASTERIDE 5 MG TABLET has declined 60.9%. It has been tracked across 669 weekly CMS publications since Dec 11, 2013.
What are the highest and lowest recorded NADAC prices for FINASTERIDE 5 MG TABLET?
Since Dec 11, 2013, the NADAC for FINASTERIDE 5 MG TABLET has ranged from a low of $0.0565 (Nov 20, 2024) to a high of $0.2514 (Feb 12, 2014), with a median of $0.0824 per EA.
Are there cheaper alternatives to FINASTERIDE 5 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FINASTERIDE 5 MG TABLET, is $0.0628 per EA — about 9% below FINASTERIDE 5 MG TABLET.
Who manufactures FINASTERIDE 5 MG TABLET?
FINASTERIDE 5 MG TABLET (NDC 76282041290) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.